ERBB2 and neoplasm: We here report that, in Her-2/neu overexpressing tumours, increased serum Her-2/neu ECD levels are indeed associated with active Her-2/neu tyrosine kinase signalling, as represented by Tyr1248-phosphorylated Her-2/neu.